Research Reports

How Patients View Current + Upcoming Weight Loss Options: A Summary of our Thrivable Q3 365 Report

The incretin market is evolving rapidly, giving patients more treatment options while making...

The Patient Journey: Discovery, Experience, and Attitudes Towards GLP-1 RAs and SGLT-2 Inhibitors Treatment

We've tapped into our patient database, comprising over 65,000 individuals living with diabetes, to...

GLP-1 RA and SGLT2-I Adoption and Retention in Patients with Diabetes

We've tapped into our patient database, comprising over 65,000 individuals living with diabetes, to...

ADA/Thrivable COVID-19 Diabetes Study: July 2021 Survey Summary Report

As part of Thrivable’s ongoing research partnership with the American Diabetes AssociationⓇ (ADA),...

ADA/Thrivable COVID-19 Diabetes Study: December 2020 Survey Summary Report

Thrivable’s first national survey in partnership with the American Diabetes AssociationⓇ (ADA)...